Chronic Fatigue Syndrome: A Treatment Guide, 2nd Edition
|Subject||Patient guide, treatment guide|
Publisher's synopsis[edit | edit source]
(This synopsis was provided by the publisher for promotional purposes. For book reviews, please see Links section below.)
This one-of-a-kind reference – now completely revised and updated – includes over 100 effective treatments, from antivirals to vitamins, as well as locations of specialists and clinics, Internet ordering information, and national, local, and international CFS/ME organizations. New and expanded sections include doctors' protocols and research on the causes and mechanisms of the illness, all written in concise, easy-to-understand language.
Every aspect of the illness is thoroughly examined, from diagnosis to an in-depth discussion of symptoms, from traditional to alternative therapies to essential coping strategies. The new edition contains chapters for those coping with multiple chemical sensitivities and dietary restrictions, as well an expanded section on children and adolescents with CFS/ME. Chronic Fatigue Syndrome: A Treatment Guide, Second Edition, remains the most comprehensive reference guide on this disease.
Links[edit | edit source]
- CFS: A Treatment Guide, 2nd Edition - Amazon (US)
- CFS: A Treatment Guide, 2nd Edition - Amazon (UK)
- CFS: A Treatment Guide, 2nd Edition - Goodreads
- CFS: A Treatment Guide, 2nd Edition - Official website
- CFS: A Treatment Guide, 2nd Edition - Facebook page
References[edit | edit source]
Myalgic encephalomyelitis (ME) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.